WE HAVE 2 NEW TYSABRI EDITORS STARTING 4/15/10! THEY WIL BE POSTING TYSABRI NEWS EVERY DAY!
Tuesday, April 20
Biogen profit, Tysabri sales disappoint
(Posted By: Josi Creek)
Biogen Idec Inc (BIIB.O) said on Tuesday that first-quarter earnings fell 11 percent, hurt by one-time charges and lower-than-expected sales of its multiple sclerosis drug Tysabri.
